These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20373128)

  • 1. Inflammatory response to percutaneous coronary intervention in stable coronary artery disease.
    Munk PS; Breland UM; Aukrust P; Skadberg O; Ueland T; Larsen AI
    J Thromb Thrombolysis; 2011 Jan; 31(1):92-8. PubMed ID: 20373128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention.
    Ozer N; Tangurek B; Firat F; Ozer S; Tartan Z; Ozturk R; Ozay B; Ciloglu F; Yilmaz H; Cam N
    Heart Vessels; 2008 Mar; 23(2):75-82. PubMed ID: 18389330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged CRP Increase After Percutaneous Coronary Intervention Is Associated with High Thrombin Concentrations and Low Platelet' Response to Clopidogrel in Patients with Stable Angina.
    Mostowik M; Siniarski A; Gołębiowska-Wiatrak R; Nessler J; Gajos G
    Adv Clin Exp Med; 2015; 24(6):979-85. PubMed ID: 26771969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble TRAIL prevents RANTES-dependent restenosis after percutaneous coronary intervention in patients with coronary artery disease.
    Satoh D; Inami N; Shimazu T; Kajiura T; Yamada K; Iwasaka T; Nomura S
    J Thromb Thrombolysis; 2010 May; 29(4):471-6. PubMed ID: 19533303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma pentraxin 3 may be a more sensitive marker of inflammatory response than high-sensitivity C-reactive protein after bare-metal stent compared to drug-eluting stent implantation.
    Hudzik B; Szkodzinski J; Pietka-Rzycka A; Danikiewicz A; Wojnar R; Lekston A; Polonski L; Zubelewicz-Szkodzinska B
    J Interferon Cytokine Res; 2013 May; 33(5):280-4. PubMed ID: 23414296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of plasma pentraxin-3 levels in patients with stable coronary artery disease after drug-eluting stent implantation.
    Haibo L; Xiaofang G; Chunming W; Jie Y; Guozhong C; Limei Z; Yong C; Yu F; Yingchun B; Wangjun Y; Junbo G
    Mediators Inflamm; 2014; 2014():963096. PubMed ID: 25538378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the systemic levels of inflammatory markers after percutaneous coronary intervention with bare metal versus sirolimus-eluting stents.
    Rebeiz AG; Zoghbi E; Harb R; Youhanna S; Skouri HN; Dimassi A; Abou-Nader G; Nasrallah A; Sawaya J; Gharzuddine W; Alam S
    J Interv Cardiol; 2009 Apr; 22(2):169-74. PubMed ID: 19245380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-Reactive Protein and Inflammatory Cytokines during Percutaneous Coronary Intervention.
    Wu M; Gu X; Li X; Li Y; Zhou H; Lu G; Wu Z; Huang H; Tang L; Zeng J
    J Vasc Res; 2016; 53(1-2):39-48. PubMed ID: 27487299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative Association of Circulating MicroRNA-126 with High-sensitive C-reactive Protein and Vascular Cell Adhesion Molecule-1 in Patients with Coronary Artery Disease Following Percutaneous Coronary Intervention.
    Wang JN; Yan YY; Guo ZY; Jiang YJ; Liu LL; Liu B
    Chin Med J (Engl); 2016 Dec; 129(23):2786-2791. PubMed ID: 27900989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrity(®) bare-metal coronary stent-induced platelet and endothelial cell activation results in a higher risk of restenosis compared to Xience(®) everolimus-eluting stents in stable angina patients.
    Szük T; Fejes Z; Debreceni IB; Kerényi A; Édes I; Kappelmayer J; Nagy B
    Platelets; 2016 Jul; 27(5):410-9. PubMed ID: 26765134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
    Simsek C; Onuma Y; Magro M; de Boer S; Battes L; van Domburg RT; Boersma E; Serruys PW;
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):41-9. PubMed ID: 20310019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
    Almagor M; Keren A; Banai S
    Am Heart J; 2003 Feb; 145(2):248-53. PubMed ID: 12595841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of changes in early inflammatory markers between sirolimus- and paclitaxel-eluting stent implantation.
    Li JJ; Yan HB; Xiang XP; Qin XW; Zhang CY
    Cardiovasc Drugs Ther; 2009 Apr; 23(2):137-43. PubMed ID: 19016317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic values of C-reactive protein levels on clinical outcome after implantation of sirolimus-eluting stents in patients on hemodialysis.
    Ishii H; Toriyama T; Aoyama T; Takahashi H; Amano T; Hayashi M; Tanaka M; Kawamura Y; Yasuda Y; Yuzawa Y; Maruyama S; Matsuo S; Matsubara T; Murohara T
    Circ Cardiovasc Interv; 2009 Dec; 2(6):513-8. PubMed ID: 20031768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble adhesion molecules in patients with acute coronary syndrome after percutaneous coronary intervention with drug-coated balloon, drug-eluting stent or bare metal stent.
    Tomulić V; Gobić D; Lulić D; Židan D; Zaputović L
    Med Hypotheses; 2016 Oct; 95():20-23. PubMed ID: 27692158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of direct sirolimus-eluting stent implantation on the early systemic inflammatory response compared with complementary stent implantation.
    Li JJ; Zhang YP; Wang C; Gao LJ; Qin XW; Xu B; Chen JL; Yang YJ; Gao RL
    Coron Artery Dis; 2009 Jan; 20(1):65-70. PubMed ID: 19018239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome.
    Gibson CM; Karmpaliotis D; Kosmidou I; Murphy SA; Kirtane AJ; Budiu D; Ray KK; Herrmann HC; Lakkis N; Kovach R; French W; Blankenship J; Lui HH; Palabrica T; Jennings LK; Cohen DJ; Morrow DA;
    Am J Cardiol; 2006 May; 97(10):1473-7. PubMed ID: 16679086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the inflammatory response between patients with and those without diabetes mellitus after coronary stenting.
    Paiva MS; Serrano CV; Nicolau JC; Jalbut BO; Fernandes JL; De Lemos JA; Blotta MH; De Oliveira RT; De Oliveira IR; De Oliveira Lda A; Ramires JA
    J Interv Cardiol; 2008 Oct; 21(5):403-9. PubMed ID: 18705636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris.
    Saleh N; Svane B; Jensen J; Hansson LO; Nordin M; Tornvall P
    Am Heart J; 2005 May; 149(5):876-82. PubMed ID: 15894971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.